MedPage Today on MSN
Personalized DNA Vaccine Shows Promise in Brain Cancer
Survival rate surpasses historical outcomes in a small phase I study ...
A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...
Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...
3don MSN
New drug candidate that reprograms the immune system shows promise as a brain cancer treatment
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...
Jason Collins, the first openly gay NBA player, has died at 47 after an eight-month battle with glioblastoma, leaving a ...
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...
Jason Collins, the NBA's first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...
Nuvation Bio Inc. (NYSE:NUVB) is one of the 10 Best Penny Stocks to Buy Before They Explode.
Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDTCompany ParticipantsDavid Hung - Founder, President, ...
Two Tasmanian researchers tackling one of the most aggressive forms of brain cancer have been awarded scholarships by Cancer ...
In an early clinical trial, a personalized vaccine safely stimulated the immune systems of people with a fatal type of brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results